Indinavir-associated lipodystrophy

AIDS

Volumn 12, Issue 6, 1998, Pages

  Viraben, Roland ^a,b   Aquilina, Christian ^a  

^a Service de Dermatologie   (France)

^b Serv Univ Psychiat l'Enfant l'A   (France)

Author keywords

Lipodystrophy; Protease inhibitor therapy; Side effect

Indexed keywords

COTRIMOXAZOLE; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; SULFAMETHOXAZOLE; TRIMETHOPRIM; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; GLUCOSE TOLERANCE TEST; GLUCOSURIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIPODYSTROPHY; LOADING TEST; MALE; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

EID: 0032537042     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199806000-00001     Document Type: Article

References (7)

1. Epstein EH: Lipodystrophy. In Dermatology in General Medicine. Edited by Fitzpatrick TB, Eisen TZ, Wolff K, Freedberg IM, Hausten KF. New York: McGraw-Hill; 1993:1347-1348.
2. Ruane PJ: Atypical accumulations of fatty tissue. 37th Interscience Conference on Antiretroviral Agents and Chemotherapy. Toronto, September 1997 [abstract 1185].
3. Sullivan AK, Nelson MR: Marked hyperlipidaemia on ritonavir therapy [letter]. AIDS 1997, 11:938-939.
4. Dube MP, Johnson DL, Currier JS, Leedom JM: Protease inhibitor-associated hyperglycaernia. Lancet 1997, 350:713-714.
5. Ipp MM, Minta JO, Gelfand EW: Disorders of the complement system in lipodystrophy. Clin Immunopathol 1977, 7:281-287.
6. Smith PM, Morgans ME, Clark CG, Lennard-Jones LE, Gunniaugsson O, Jonasson TA: Lipodystrophy, pancreatitis, and eosinophilia. Gut 1975, 16:230-234.
7. O'Mahony D, O'Mahony S, Whelton MJ: Partial lipodystrophy in coeliac disease. Gut 1990, 31:717-718.